Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Shares Outstanding (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Shares Outstanding for 2 consecutive years, with $39.1 million as the latest value for Q3 2017.

  • Quarterly Shares Outstanding rose 0.64% to $39.1 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $39.1 million through Sep 2017, up 0.64% year-over-year, with the annual reading at $3.9 million for FY2016, N/A changed from the prior year.
  • Shares Outstanding for Q3 2017 was $39.1 million at Bone Biologics, up from $38.8 million in the prior quarter.
  • The five-year high for Shares Outstanding was $39.1 million in Q3 2017, with the low at $3.9 million in Q4 2016.